Navigation Links
Head of Process Sciences at aTyr Pharma to Speak at Bio Korea 2009
Date:9/1/2009

SAN DIEGO, Sept. 1 /PRNewswire/ -- Chulho Park, Ph. D., Head of Process Sciences at aTyr Pharma, a privately held biopharmaceutical company focused on discovery and development of a newly emerging class of natural biotherapeutics, will be a featured speaker at Bio Korea 2009. On September 18, 2009, Dr. Park will present his talk "Selecting the Optimal Biotherapeutic Candidate for Development" at the conference, taking place in Seoul, Korea. In his presentation, Dr. Park will discuss key steps required to create a development process for a new biotherapeutic, and how he has applied his experience to optimizing the development pathway for the lead program at aTyr Pharma. aTyr's lead program, scheduled for a pre-IND meeting at the FDA in September, is a novel protein therapeutic, ATYR0030, with thrombopoietic activity that is initially being developed to treat thrombocytopenia in patients with myelodyspastic syndromes (MDS).

After completing a Ph. D. at Korea University and postdoctoral training at Stanford University, Dr. Park has spent 9 years in the pharmaceutical industry focused on process development for biotherapeutics, including experience with 8 proteins that have reached the clinical development stage. According to Alain Vasserot, Ph. D., Executive Director of Preclinical Development at aTyr Pharma, "Dr. Park adds valuable drug development expertise to aTyr Pharma. His experience and perspective have been an essential driver in our rapid development of ATYR0030. Dr. Park's talk at Bio Korea 2009 will give attendees a prime opportunity to gain perspective from a highly skilled practitioner in the biotherapeutic development field."

Jeff Watkins, the CEO of aTyr Pharma adds, "Dr. Park is a vital component of our strong biologics development team, a strength that distinguishes aTyr Pharma from many other biotechnology companies. With the current emphasis on protein biologics, most pharmaceutical companies are looking to novel biotherapeutics to provide new treatments for human diseases. Scientific leaders in our sector understand the unique issues and challenges associated with process development for protein therapeutics, and we are pleased that the organizers of Bio Korea 2009 recognize the value of sharing Dr. Park's perspectives in biotherapeutic development."

About aTyr Pharma

aTyr Pharma, Inc. is a biopharmaceutical company focused on the discovery of an entirely new class of biologics. aTyr Pharma's discovery engine for new biotherapeutics consists of novel proteins in the family of tRNA synthetases with cell signaling activities distinct from the protein synthesis activities commonly associated with the tRNA synthetases. These resected proteins, or "resectins," are being developed as novel therapeutics to treat hematological disorders, neurodegenerative diseases, inflammation, cardiovascular diseases and metabolic disorders.

www.atyrpharma.com


'/>"/>
SOURCE aTyr Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
2. Raydiance Collaborates With Rutgers University and Nations Largest Tissue Bank to Develop Innovative Tissue Processing Approaches
3. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
4. Brain Waves Show Sound Processing Abnormalities in Autistic Children
5. Stress-Related Disorders Affect Brains Processing of Memory
6. Verification Studies of IntelligentMDxs Proprietary Molecular Diagnostic Assay Process Have Been Completed
7. Processed Tomato Products May Protect Against Inflammation, According to a Study Presented at the Experimental Biology Meeting
8. Smithfield Sends Update to Employees on Testing Process at Veracruz Joint Venture
9. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
10. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
11. Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/5/2017)... 5, 2017  In response to the nationwide ... Maxillofacial Surgeons (AAOMS) released prescribing recommendations that urge ... used as a first-line therapy to manage a ... Recognizing the value and importance ... "Opioid Prescribing: Acute and Postoperative Pain Management" stresses ...
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation announce a ... sensors for real-time monitoring of patients with trauma-related and ... focused on disruptive health solutions for rare disorders and ... record and integrate behavioral, cognitive, physiological and contextual data. ... ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... process to promote standards of excellence for the field of eating disorders, announces ... 22 – 25, 2018 in Orlando, Florida at the Omni Resort at ChampionsGate. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder of the ... a national organization of elder law and special needs planning attorneys. “Membership in ElderCounsel ... also provides a forum to network with elder law attorneys nationwide,” said Somekh. ...
(Date:10/13/2017)... ... 2017 , ... The Visiting Nurse Association (VNA) of Somerset Hills is proud ... and unique items from across the nation, this holiday-themed event will raise funds and ... the VNA. The boutique will be open Saturday, November 4 (10:00 a.m. – ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at ... of the most popular and least understood books in the Holy Scriptures, Revelation. The ... that have baffled scholars for centuries. Many have tossed it off as mere rubbish, ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
Breaking Medicine News(10 mins):